Article
Response-guided therapy in patients with genotype 1 hepatitis C virus: current status and future prospects.
Journal of gastroenterology and hepatology - 1 Aug 2014
Lawitz Eric J, Membreno Fernando E
Abstract excerpt
On-treatment responses to antiviral therapy are used to determine duration of therapy in patients being treated for genotype 1 hepatitis C virus infection. Such use of response-guided therapy has successfully reduced exposure of patients to the side-effects of pegylated interferon and ribavirin without jeopardizing overall treatment success. Response-guided therapy is an integral part of treatment using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
